ACCUPRIL

Brand name authorized in: Australia Canada United States

Active ingredients

The drug ACCUPRIL contains one active pharmaceutical ingredient (API):

1 Quinapril
UNII 33067B3N2M - QUINAPRIL HYDROCHLORIDE

Quinapril is a potent angiotensin-converting enzyme (ACE) inhibitor. The mode of action of quinapril in humans and animals is to inhibit circulating and tissue ACE activity, thereby decreasing vasopressor activity and aldosterone secretion.

Read about Quinapril

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Quinapril
C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA06

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Structured product labeling (SPL)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
AU
Pharmaceutical Benefits Scheme
Identifier(s): 1968N, 1969P, 1970Q
CA
Health Products and Food Branch
Identifier(s): 01947664, 01947672, 01947680, 01947699
US
FDA, National Drug Code
Identifier(s): 0071-0527, 0071-0530, 0071-0532, 0071-0535